These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14552798)

  • 1. X-ray structures of two xanthine inhibitors bound to PEPCK and N-3 modifications of substituted 1,8-dibenzylxanthines.
    Foley LH; Wang P; Dunten P; Ramsey G; Gubler ML; Wertheimer SJ
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3871-4. PubMed ID: 14552798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified 3-alkyl-1,8-dibenzylxanthines as GTP-competitive inhibitors of phosphoenolpyruvate carboxykinase.
    Foley LH; Wang P; Dunten P; Ramsey G; Gubler ML; Wertheimer SJ
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3607-10. PubMed ID: 14505680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human cytosolic phosphoenolpyruvate carboxykinase reveals a new GTP-binding site.
    Dunten P; Belunis C; Crowther R; Hollfelder K; Kammlott U; Levin W; Michel H; Ramsey GB; Swain A; Weber D; Wertheimer SJ
    J Mol Biol; 2002 Feb; 316(2):257-64. PubMed ID: 11851336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-8 Modifications of 3-alkyl-1,8-dibenzylxanthines as inhibitors of human cytosolic phosphoenolpyruvate carboxykinase.
    Pietranico SL; Foley LH; Huby N; Yun W; Dunten P; Vermeulen J; Wang P; Toth K; Ramsey G; Gubler ML; Wertheimer SJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3835-9. PubMed ID: 17532214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and structural analysis of Escherichia coli phosphoenolpyruvate carboxykinase mutants.
    Sokaribo A; Novakovski BAA; Cotelesage J; White AP; Sanders D; Goldie H
    Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129517. PubMed ID: 31911238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structures of rat cytosolic PEPCK: insight into the mechanism of phosphorylation and decarboxylation of oxaloacetic acid.
    Sullivan SM; Holyoak T
    Biochemistry; 2007 Sep; 46(35):10078-88. PubMed ID: 17685635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural investigation of the binding of nucleotide to phosphoenolpyruvate carboxykinase by NMR.
    Holyoak T; Nowak T
    Biochemistry; 2001 Sep; 40(37):11037-47. PubMed ID: 11551200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of the gene encoding ATP-dependent phospho-enol-pyruvate carboxykinase in Trypanosoma cruzi: comparison of primary and predicted secondary structure with host GTP-dependent enzyme.
    Linss J; Goldenberg S; Urbina JA; Amzel LM
    Gene; 1993 Dec; 136(1-2):69-77. PubMed ID: 8294043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of the dimeric phosphoenolpyruvate carboxykinase (PEPCK) from Trypanosoma cruzi at 2 A resolution.
    Trapani S; Linss J; Goldenberg S; Fischer H; Craievich AF; Oliva G
    J Mol Biol; 2001 Nov; 313(5):1059-72. PubMed ID: 11700062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Control of Nonnative Ligand Binding in Engineered Mutants of Phosphoenolpyruvate Carboxykinase.
    Tang HYH; Shin DS; Hura GL; Yang Y; Hu X; Lightstone FC; McGee MD; Padgett HS; Yannone SM; Tainer JA
    Biochemistry; 2018 Dec; 57(48):6688-6700. PubMed ID: 30376300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthine mimetics as potent dipeptidyl peptidase IV inhibitors.
    Kurukulasuriya R; Rohde JJ; Szczepankiewicz BG; Basha F; Lai C; Jae HS; Winn M; Stewart KD; Longenecker KL; Lubben TW; Ballaron SJ; Sham HL; von Geldern TW
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6226-30. PubMed ID: 17010607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology and preclinical validation of a novel anticancer compound targeting PEPCK-M.
    Aragó M; Moreno-Felici J; Abás S; Rodríguez-Arévalo S; Hyroššová P; Figueras A; Viñals F; Pérez B; Loza MI; Brea J; Latorre P; Carrodeguas JA; García-Rovés PM; Galdeano C; Ginex T; Luque FJ; Escolano C; Perales JC
    Biomed Pharmacother; 2020 Jan; 121():109601. PubMed ID: 31739159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A GTP-dependent Phosphoenolpyruvate Carboxykinase from Crassostrea gigas Involved in Immune Recognition.
    Lv Z; Qiu L; Wang W; Liu Z; Xue Z; Yu Z; Song X; Chen H; Wang L; Song L
    Dev Comp Immunol; 2017 Dec; 77():318-329. PubMed ID: 28888537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of pyruvate kinase and phosphoenolpyruvate carboxykinase in the adductor muscle of the oyster Crassostrea gigas during prolonged hypoxia.
    Le Moullac G; Bacca H; Huvet A; Moal J; Pouvreau S; Van Wormhoudt A
    J Exp Zool A Ecol Genet Physiol; 2007 Jul; 307(7):371-82. PubMed ID: 17486628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis and biological activity of substituted xanthines as DPP-Ⅳ inhibitors].
    Li YP; Yi H; Jiang XB; Li ZR
    Yao Xue Xue Bao; 2016 Jun; 51(6):947-53. PubMed ID: 29879349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoenolpyruvate carboxykinase is involved in antiviral immunity against Bombyx mori nucleopolyhedrovirus.
    Guo H; Xu G; Wang B; Xia F; Sun Q; Wang Y; Xie E; Lu Z; Jiang L; Xia Q
    Dev Comp Immunol; 2019 Mar; 92():193-198. PubMed ID: 30471302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocomputational analysis of phosphoenolpyruvate carboxykinase from Raillietina echinobothrida, a cestode parasite, and its interaction with possible modulators.
    Dutta AK; Ramnath ; Tandon V; DAS B
    Parasitology; 2016 Mar; 143(3):300-13. PubMed ID: 26690489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of phosphorylation on phosphoenolpyruvate carboxykinase from the C4 plant Guinea grass.
    Walker RP; Chen ZH; Acheson RM; Leegood RC
    Plant Physiol; 2002 Jan; 128(1):165-72. PubMed ID: 11788762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
    Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
    Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists.
    Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA
    Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.